ADRNY or CLX: Which Is the Better Value Stock Right Now?

According to Zacks, Ahold NV (ADRNY) is a better value stock compared to Clorox (CLX) based on their Zacks Rank and Style Scores. ADRNY has a Zacks Rank of #2 (Buy) versus CLX's #4 (Sell), coupled with a Value grade of A compared to CLX's D; ADRNY also exhibits more attractive valuation metrics, including a lower forward P/E ratio (14.25 vs 18.34), PEG ratio (1.66 vs 2.94), and P/B ratio (2.34 vs 84.39).

Analysis

A comparative analysis within the Consumer Products - Staples sector indicates Ahold NV (ADRNY) presents a more compelling value proposition than Clorox (CLX), according to Zacks' proprietary models. ADRNY holds a Zacks Rank of #2 (Buy), signifying positive earnings estimate revision trends, contrasting with CLX's Zacks Rank of #4 (Sell). This difference suggests an improving earnings outlook for ADRNY relative to CLX. Further reinforcing this view, ADRNY scores an 'A' in Zacks' Value Style Score, while CLX receives a 'D'. Key valuation metrics support this differentiation: ADRNY's forward Price-to-Earnings (P/E) ratio is 14.25, notably lower than CLX's 18.34. Additionally, ADRNY's Price/Earnings-to-Growth (PEG) ratio stands at 1.66, compared to CLX's 2.94, indicating ADRNY is more attractively valued relative to its expected earnings growth. The Price-to-Book (P/B) ratio also heavily favors ADRNY at 2.34, versus an exceptionally high 84.39 for CLX. These metrics, combined with the Zacks Rank and Style Scores, suggest ADRNY is currently undervalued compared to CLX. The per-ticker sentiment scores, with ADRNY at a positive 0.8 and CLX at a negative -0.8, align with this analytical conclusion.

Key Decisions for Investors

• Value-oriented investors in the consumer staples sector should consider Ahold NV (ADRNY) due to its favorable Zacks Rank, superior Value Grade, and more attractive P/E, PEG, and P/B ratios compared to Clorox (CLX).
• Given Clorox's (CLX) 'Sell' rating from Zacks, its lower Value Grade, and significantly higher valuation multiples, investors may find it prudent to re-evaluate existing positions in CLX or exercise caution before initiating new ones.
• Monitor ongoing earnings estimate revisions for both ADRNY and CLX, as these are key drivers for the Zacks Rank and can signal shifts in their respective investment outlooks.